Shahram Salek-Ardakani

Insider Reports History

Location
La Jolla, CA
Signature
/s/ Maria Dobek, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shahram Salek-Ardakani:

Company Role Class Num Shares Value Price $ Report Date Ownership
Janux Therapeutics, Inc. Chief Scientific Officer Stock Option (right to buy) 114,250 03 Jan 2022 Direct

Insider Reports Filed by Shahram Salek-Ardakani

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JANX Janux Therapeutics, Inc. 03 Jan 2022 1 $0 4 Chief Scientific Officer 05 Jan 2022, 16:28
JANX Janux Therapeutics, Inc. 12 Jul 2021 0 $0 3 Chief Scientific Officer 20 Jul 2021, 16:44